1.23 USD
↘ 0.06 (4.65%)AT CLOSE (11:59 AM EDT)
Milestone Pharmaceuticals Inc. Common Shares
MISTNASDAQ • USD
1.24
↗ 0.01 (0.81%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
1.24
↗ 0.01 (0.81%)
Market: CLOSED
Open?$1.28
High?$1.28
Low?$1.21
Prev. Close?$1.29
Volume?2.4M
Avg. Volume?1.3M
VWAP?$1.24
Rel. Volume?1.81x
Bid / Ask
Bid?$1.05 × 100
Ask?$1.44 × 100
Spread?$0.39
Midpoint?$1.25
Valuation & Ratios
Market Cap?153.1M
Shares Out?124.5M
Float?104.3M
Float %?87.2%
P/E Ratio?N/A
P/B Ratio?-7.81
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
Shares of Milestone Pharmaceuticals Inc. Common Shares (MIST) are trading at $1.23. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (348.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, MIST is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Employees
38
Market Cap
153.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-09
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.91Distress
Confidence?51%Low
Short InterestElevated
Short % of Float?7.17%Elevated
Short Interest?7.5M
Days to Cover?4.3
Free Float104.3M
Avg Daily Volume1.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?9.18Strong
Quick Ratio?9.09Strong
Cash Ratio?3.41Strong
Debt/Equity?-6.95Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-7.81CHEAP▾
S&P97
P/S?85.84HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
S&P97
EV/Sales?122.26HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?348.8%STRONG▾
Peers50
S&P97
ROA?-35.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51483000
Enterprise Value?$218.1M
Fundamentals ratios updated end of day